Microsatellite Instability Testing
The latest news on microsatellite instability testing.
Imidex, Orbit Genomics Partner to Develop Lung Cancer Detection Technologies
The collaboration aims to increase early detection rates for lung cancer via improved imaging of suspected nodules and subsequent genomic testing.
Owkin Expands Into Western Europe With Nine Precision Medicine Partnerships
The firm will employ its machine learning-enabled diagnostic and drug discovery tools in nine centers across Germany, Austria, and Switzerland.
Promega to Develop Microsatellite Instability Companion Diagnostic Kit With GlaxoSmithKline
The IVD kit will be used to identify patients with the MSI biomarker who may be eligible for potential treatment with GSK's Jemperli (dostarlimab-gxly).
Large Study of Early-Onset Colorectal Cancer Patients IDs Unique, Potentially Actionable Mutations
In younger patients, HER2 mutations were more prevalent in those who had MSI-high/TMB-high tumors, while POLE mutations were more common in MSS/TMB-high tumors, researchers reported at ASCO.
Tempus Gains FDA Premarket Approval for NGS Solid Tumor Profiling Test
The xT CDx is a 648-gene next-generation sequencing test that can help guide treatments for colorectal cancer patients with targeted therapies.